Magnetic tracer in the sentinel node procedure in breast cancer: the non-radioactive alternative for radio-isotopes
Completed
- Conditions
- sentinel node procedure1000629110006295
- Registration Number
- NL-OMON49099
- Lead Sponsor
- Zuyderland Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
In order to be eligible to participate in this study, a subject must meet all
of the following criteria:
- Female patient of 18 years or older.
- Patient with breast cancer and indication for sentinel node procedure.
Exclusion Criteria
A potential subject who meets any of the following criteria will be excluded
from participation in this study:
- Patients with a previous history of the sentinel node procedure or
axillary lymph node dissection in the ipsilateral breast.
- Hypersensitivity for ironoxide or dextran
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>To assess<br /><br>1. The concordance in detection of sentinel nodes by Magtrace and the<br /><br>Technetium tracer. </p><br>
- Secondary Outcome Measures
Name Time Method <p>1. Operation time sentinel node procedure</p><br>